We are live on
!
Find out more
Iovance Biotherapeutics
IOVA
IOVA
139 hedge funds and large institutions have $1.05B invested in Iovance Biotherapeutics in 2018 Q4 according to their latest regulatory filings, with 33 funds opening new positions, 67 increasing their positions, 28 reducing their positions, and 25 closing their positions.
New
Increased
Maintained
Reduced
Closed
171% more call options, than puts
Call options by funds: $1.53M | Put options by funds: $567K
139% more repeat investments, than reductions
Existing positions increased: 67 | Existing positions reduced: 28
32% more first-time investments, than exits
New positions opened: 33 | Existing positions closed: 25
14% more funds holding in top 10
Funds holding in top 10: 7 → 8 (+1)
6% more funds holding
Funds holding: 131 → 139 (+8)
1.59% more ownership
Funds ownership: 94.66% → 96.25% (+1.6%)
3% more capital invested
Capital invested by funds: $1.02B → $1.05B (+$30.8M)
Holders
139
Holders Change
+8
Holders Change %
+6.11%
% of All Funds
3.1%
Holding in Top 10
8
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+14.29%
% of All Funds
0.18%
New
33
Increased
67
Reduced
28
Closed
25
Calls
$1.53M
Puts
$567K
Net Calls
+$968K
Net Calls Change
-$2.56M
Top Buyers
| 1 |
PA
Perceptive Advisors
New York
|
+$47.7M |
| 2 |
Franklin Resources
San Mateo,
California
|
+$29.9M |
| 3 |
BlackRock
New York
|
+$20.5M |
| 4 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
+$20M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$16.7M |
